EA200100785A1 - FROZEN WEAKNESSES - Google Patents

FROZEN WEAKNESSES

Info

Publication number
EA200100785A1
EA200100785A1 EA200100785A EA200100785A EA200100785A1 EA 200100785 A1 EA200100785 A1 EA 200100785A1 EA 200100785 A EA200100785 A EA 200100785A EA 200100785 A EA200100785 A EA 200100785A EA 200100785 A1 EA200100785 A1 EA 200100785A1
Authority
EA
Eurasian Patent Office
Prior art keywords
weaknesses
frozen
coprostasis
mammal
human
Prior art date
Application number
EA200100785A
Other languages
Russian (ru)
Other versions
EA003064B1 (en
Inventor
Брюс Р. Дэгги
Кеннет Дж. Мэндел
Original Assignee
Смитклайн Бичем Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичем Корпорейшн filed Critical Смитклайн Бичем Корпорейшн
Publication of EA200100785A1 publication Critical patent/EA200100785A1/en
Publication of EA003064B1 publication Critical patent/EA003064B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к новой осмотической/шипучей системе для лечения запора и копростаза у человека или млекопитающего, нуждающегося в таком лечении.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to a new osmotic / effervescent system for treating constipation and coprostasis in a human or mammal in need of such treatment. The international application was published along with an international search report.

EA200100785A 1999-02-22 2000-02-22 Effervescent laxatives EA003064B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12108999P 1999-02-22 1999-02-22
PCT/US2000/004701 WO2000048585A1 (en) 1999-02-22 2000-02-22 Effervescent laxatives

Publications (2)

Publication Number Publication Date
EA200100785A1 true EA200100785A1 (en) 2002-04-25
EA003064B1 EA003064B1 (en) 2002-12-26

Family

ID=22394460

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100785A EA003064B1 (en) 1999-02-22 2000-02-22 Effervescent laxatives

Country Status (14)

Country Link
EP (1) EP1154765A4 (en)
JP (1) JP2002537248A (en)
KR (1) KR20010102323A (en)
CN (1) CN1341016A (en)
AU (1) AU3604600A (en)
BR (1) BR0008385A (en)
CA (1) CA2362355A1 (en)
CZ (1) CZ20013043A3 (en)
EA (1) EA003064B1 (en)
HK (1) HK1043046A1 (en)
HU (1) HUP0105351A3 (en)
PL (1) PL349360A1 (en)
WO (1) WO2000048585A1 (en)
ZA (1) ZA200106888B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation
DE102004023288A1 (en) * 2004-05-11 2005-12-15 Stefan Spiess Macrogol preparation
AU2005320935B2 (en) * 2004-12-30 2012-02-16 Given Imaging Ltd. Device, system and method for in-vivo examination
CN101002832B (en) * 2006-09-02 2011-01-05 江西农业大学 Granulated quickly dissolving medicine for relaxing bowel
LT2421373T (en) 2009-04-21 2020-01-10 Dale R. Bachwich Colon lavage system
CA2825808C (en) 2011-01-28 2020-09-01 William A. Shaver Method, composition and package for bowel cleansing
EP2773362A4 (en) * 2011-11-06 2015-08-26 Ssv Therapeutics Llc Formulations of concentrated prunes and prebiotics as laxatives and dietary supplements

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB942743A (en) * 1959-05-22 1963-11-27 Welloome Foundation Ltd Oestrogen preparations and the manufacture thereof
GB1518364A (en) * 1976-05-05 1978-07-19 Beecham Group Ltd Pharmaceutical composition
US4093710A (en) * 1976-07-07 1978-06-06 Sandoz, Inc. Rapid dissolving effervescent granules
JPH01283222A (en) * 1988-05-10 1989-11-14 Tokai Kapuseru Kk Soft capsule agent of sodium picosulfate
IT1229568B (en) * 1989-04-17 1991-09-04 Giuliani Spa PHARMACEUTICAL COMPOSITION FOR ORAL USE SUITABLE FOR USE IN GASTRO-INTESTINAL WASHING, IN PARTICULAR FOR DIAGNOSTIC USE, OR AS A CATHARTIC LAXATIVE.
US4946939A (en) * 1989-05-30 1990-08-07 The Dow Chemical Company High purity polyether polyols
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation

Also Published As

Publication number Publication date
WO2000048585A1 (en) 2000-08-24
EP1154765A4 (en) 2004-12-01
EP1154765A1 (en) 2001-11-21
CA2362355A1 (en) 2000-08-24
HK1043046A1 (en) 2002-09-06
BR0008385A (en) 2002-01-29
HUP0105351A2 (en) 2002-05-29
PL349360A1 (en) 2002-07-15
AU3604600A (en) 2000-09-04
CZ20013043A3 (en) 2001-11-14
KR20010102323A (en) 2001-11-15
EA003064B1 (en) 2002-12-26
HUP0105351A3 (en) 2004-06-28
ZA200106888B (en) 2002-09-27
CN1341016A (en) 2002-03-20
JP2002537248A (en) 2002-11-05

Similar Documents

Publication Publication Date Title
ATE350044T1 (en) THROMBOPOIETIN MIMETICS
DE60025632D1 (en) Thrombopoietin mimetics
DE122009000012I1 (en) Substituted pyrazolylbenzenesulfonamides for the treatment of inflammation.
EA199801044A1 (en) TISSUE REGENERATION MODULATORS
ID29244A (en) NON-PEPTID GnRH SUBSTANCE, METHODS AND SUBSTANCE BETWEEN THEIR PRODUCTION
EA199800946A1 (en) CONCENTRATED ANTIBODY PREPARATION
EA200100572A1 (en) METHOD OF APPLICATION OF CYCLOOXIGENASE-2 INHIBITOR AND ONE OR MULTIPLE ANTITUMOR MEDICINES AS A COMBINED METHOD OF MEDICAL EXPOSURE IN THE TREATMENT OF NEOPLASIA
MX9606386A (en) Agents affecting thrombosis hemostasis.
EA199800667A1 (en) NEW PHENANTRIDINES
EA200000911A1 (en) NEW CRYSTAL FORMS OF ANTI-VIRUS COMPOUND OF BENZIMIDAZOLE
ATE344031T1 (en) THROMBOPOIETIN MIMETICS
DE60032795D1 (en) NORDIHYDROGUAIARETINIC ACID DERIVATIVES FOR THE TREATMENT OF TUMORS
DE69929464D1 (en) CYCLIC POLYAMINES FOR THE TREATMENT OF THROMBOCYTOPENIA
EA200401341A1 (en) APPLICATION OF OSTEOPROTEGERIN FOR THE TREATMENT AND / OR PREVENTION OF FIBROUS DISEASE
DE69711078D1 (en) TOPICAL USE OF KAPPA OPIOID RECEPTORAGONISTS FOR THE TREATMENT OF EYE PAIN
EA200100785A1 (en) FROZEN WEAKNESSES
EA199800717A1 (en) METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION
PT1051187E (en) TREATMENT OF FOLLICULAR LYMPHOMAS USING LYMPHOTOXIN (LT) VIA INHIBITORS
TR200103125T2 (en) Anticonvulsant derivatives for use in improving autism.
ATE261724T1 (en) ANTICONVULSIVE DERIVATIVES FOR THE TREATMENT OF POST-TRAAUMATIC STRESS DISEASES
PT1092040E (en) METHODS OF INHIBIT HELICOBACTER PYLORI
DE69818809D1 (en) METHOD FOR TREATING SCAR TISSUE
EA200000875A1 (en) PROTEINS INTERACTING WITH CASPASE-8
EA200200798A1 (en) CALCYLYTIC COMPOUNDS
EA199900579A1 (en) APPLICATION OF COMT INHIBITORS FOR THE PRODUCTION OF MEDICINES FOR THE PREVENTION OF VASCULAR DYSFUNCTION IN DIABETES

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU